Diamonds and Dogs


Sage Therapeutics (SAGE) looks wise. The drug company's stock is up 75% just today thanks to positive mid-stage study results for their depression drug. The 89-patient study testing the drug, SAGE-217, showed statistically significant reduction of depression symptoms, when compared to a placebo. Depression is a common mental illness characterized by persistent sadness and a loss of interest and lack of ability to do everyday activities and work. The drug was granted fast-track designation by the U.S. Food and Drug Administration in back in May.

Lending Club (LC) may need a loan of their own. The financial company is down 14% to a new low after lowering its outlook for the fourth quarter and delivering a lower-than-expected forecast for next year. The stock is down 40% since October and down 85% since coming public at the end of 2014. Not a bright future for Lending Club.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.